Cathleen O’Grady

Mar 7, 2024 | spectrumnews.org | Cathleen O’Grady

Cathleen O’Grady is a freelance science journalist based in Scotland. Her work has appeared in The Atlantic, Hakai, National Geographic and Science, among others. She covers behavioral and life sciences, research integrity and science policy.

Mar 5, 2024 | thetransmitter.org | Cathleen O’Grady |Shaena Montanari |Laura Dattaro |Gina Jimenez

Cathleen O’Grady is a freelance science journalist based in Scotland. Her work has appeared in The Atlantic, Hakai, National Geographic and Science, among others. She covers behavioral and life sciences, research integrity and science policy. Spectrum By Cathleen O’Grady 7 March 2024 3 min read The U.K.-based genetics study launched the consultation more than a year ago in response to fierce criticism from autistic self-advocates.

Nov 6, 2023 | thetransmitter.org | Shaena Montanari |Cathleen O’Grady |Laura Dattaro |Gina Jimenez

Retraction By Shaena Montanari 7 March 2024 3 min read The retraction follows an editorial expression of concern that the journal applied to the paper in October, seven months after it was published in the Proceedings of the National Academy of Sciences.

Jun 5, 2023 | fal.cn | Cathleen O’Grady

Psychedelic drugs, best known for causing hallucinations, can also lift users’ moods, preliminary results from clinical trials suggest. But the risks that come with the trip are an obstacle to using the drugs as antidepressants. Hallucinations might trigger psychosis in people with certain risk factors, and because of their unpredictable effects, clinicians have to closely monitor patients as they take the drugs. Now, researchers think they may be able to take hallucinations out of the equation.